BIOMAT Database Logo BIOMAT Database Logo

A cystic fibrosis child with lung function decline. 2019

Ersilia Vita Fiscarelli, and Gabriella Ricciotti, and Martina Rossitto, and Arianna Pompilio, and Vanessa Tuccio Guarna Assanti, and Vincenzina Lucidi
Laboratory Department, Children's Hospital and Research Institute Bambino Gesù, Rome, Italy. Electronic address: evita.fiscarelli@opbg.net.

Respiratory infections are a major threat to cystic fibrosis patients. Besides bacteria, many fungi colonize the cystic fibrosis respiratory tract where an important fungal biota has been described. We report here the case of a 7-year-old cystic fibrosis child with pulmonary exacerbation and Arthrographis kalrae isolated from bronchoalveolar lavage fluid. To the best of our knowledge, this is the first reported case of lung infection due to Arhtrographis kalrae in a cystic fibrosis pediatric patient.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008172 Lung Diseases, Fungal Pulmonary diseases caused by fungal infections, usually through hematogenous spread. Fungal Lung Diseases,Pulmonary Fungal Infections,Pulmonary Fungal Diseases,Fungal Disease, Pulmonary,Fungal Diseases, Pulmonary,Fungal Infection, Pulmonary,Fungal Infections, Pulmonary,Fungal Lung Disease,Lung Disease, Fungal,Pulmonary Fungal Disease,Pulmonary Fungal Infection
D008297 Male Males
D012129 Respiratory Function Tests Measurement of the various processes involved in the act of respiration: inspiration, expiration, oxygen and carbon dioxide exchange, lung volume and compliance, etc. Lung Function Tests,Pulmonary Function Tests,Function Test, Pulmonary,Function Tests, Pulmonary,Pulmonary Function Test,Test, Pulmonary Function,Tests, Pulmonary Function,Function Test, Lung,Function Test, Respiratory,Function Tests, Lung,Function Tests, Respiratory,Lung Function Test,Respiratory Function Test,Test, Lung Function,Test, Respiratory Function,Tests, Lung Function,Tests, Respiratory Function
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D001203 Ascomycota A phylum of fungi which have cross-walls or septa in the mycelium. The perfect state is characterized by the formation of a saclike cell (ascus) containing ascospores. Most pathogenic fungi with a known perfect state belong to this phylum. Ascomycetes,Cochliobolus,Sclerotinia,Ascomycete,Ascomycotas,Sclerotinias

Related Publications

Ersilia Vita Fiscarelli, and Gabriella Ricciotti, and Martina Rossitto, and Arianna Pompilio, and Vanessa Tuccio Guarna Assanti, and Vincenzina Lucidi
Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline.
January 2016, PloS one,
Ersilia Vita Fiscarelli, and Gabriella Ricciotti, and Martina Rossitto, and Arianna Pompilio, and Vanessa Tuccio Guarna Assanti, and Vincenzina Lucidi
Infection, inflammation, and lung function decline in infants with cystic fibrosis.
July 2011, American journal of respiratory and critical care medicine,
Ersilia Vita Fiscarelli, and Gabriella Ricciotti, and Martina Rossitto, and Arianna Pompilio, and Vanessa Tuccio Guarna Assanti, and Vincenzina Lucidi
Decline in lung function does not predict future decline in lung function in cystic fibrosis patients.
September 2015, Pediatric pulmonology,
Ersilia Vita Fiscarelli, and Gabriella Ricciotti, and Martina Rossitto, and Arianna Pompilio, and Vanessa Tuccio Guarna Assanti, and Vincenzina Lucidi
Rapid lung function decline in adults with early-stage cystic fibrosis lung disease.
July 2020, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society,
Ersilia Vita Fiscarelli, and Gabriella Ricciotti, and Martina Rossitto, and Arianna Pompilio, and Vanessa Tuccio Guarna Assanti, and Vincenzina Lucidi
Correction: Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline.
January 2016, PloS one,
Ersilia Vita Fiscarelli, and Gabriella Ricciotti, and Martina Rossitto, and Arianna Pompilio, and Vanessa Tuccio Guarna Assanti, and Vincenzina Lucidi
Increased rate of lung function decline in Australian adolescents with cystic fibrosis.
September 2014, Pediatric pulmonology,
Ersilia Vita Fiscarelli, and Gabriella Ricciotti, and Martina Rossitto, and Arianna Pompilio, and Vanessa Tuccio Guarna Assanti, and Vincenzina Lucidi
A semiparametric approach to estimate rapid lung function decline in cystic fibrosis.
December 2013, Annals of epidemiology,
Ersilia Vita Fiscarelli, and Gabriella Ricciotti, and Martina Rossitto, and Arianna Pompilio, and Vanessa Tuccio Guarna Assanti, and Vincenzina Lucidi
Rate of Lung Function Decline in People with Cystic Fibrosis Having a Residual Function Gene Mutation.
December 2022, Pulmonary therapy,
Ersilia Vita Fiscarelli, and Gabriella Ricciotti, and Martina Rossitto, and Arianna Pompilio, and Vanessa Tuccio Guarna Assanti, and Vincenzina Lucidi
Inhaled corticosteroids and lower lung function decline in young children with cystic fibrosis.
May 2011, The European respiratory journal,
Ersilia Vita Fiscarelli, and Gabriella Ricciotti, and Martina Rossitto, and Arianna Pompilio, and Vanessa Tuccio Guarna Assanti, and Vincenzina Lucidi
Factors in childhood associated with lung function decline to adolescence in cystic fibrosis.
November 2022, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society,
Copied contents to your clipboard!